[go: up one dir, main page]

AUPR589701A0 - Novel peptide and use thereof - Google Patents

Novel peptide and use thereof

Info

Publication number
AUPR589701A0
AUPR589701A0 AUPR5897A AUPR589701A AUPR589701A0 AU PR589701 A0 AUPR589701 A0 AU PR589701A0 AU PR5897 A AUPR5897 A AU PR5897A AU PR589701 A AUPR589701 A AU PR589701A AU PR589701 A0 AUPR589701 A0 AU PR589701A0
Authority
AU
Australia
Prior art keywords
novel peptide
peptide
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR5897A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPR5897A priority Critical patent/AUPR589701A0/en
Publication of AUPR589701A0 publication Critical patent/AUPR589701A0/en
Priority to AU2001288087A priority patent/AU2001288087A1/en
Priority to PCT/JP2001/008221 priority patent/WO2003000718A2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPR5897A 2001-06-22 2001-06-22 Novel peptide and use thereof Abandoned AUPR589701A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPR5897A AUPR589701A0 (en) 2001-06-22 2001-06-22 Novel peptide and use thereof
AU2001288087A AU2001288087A1 (en) 2001-06-22 2001-09-21 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjogren's syndrome
PCT/JP2001/008221 WO2003000718A2 (en) 2001-06-22 2001-09-21 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR5897A AUPR589701A0 (en) 2001-06-22 2001-06-22 Novel peptide and use thereof

Publications (1)

Publication Number Publication Date
AUPR589701A0 true AUPR589701A0 (en) 2001-07-19

Family

ID=3829866

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPR5897A Abandoned AUPR589701A0 (en) 2001-06-22 2001-06-22 Novel peptide and use thereof
AU2001288087A Abandoned AU2001288087A1 (en) 2001-06-22 2001-09-21 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjogren's syndrome

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001288087A Abandoned AU2001288087A1 (en) 2001-06-22 2001-09-21 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjogren's syndrome

Country Status (2)

Country Link
AU (2) AUPR589701A0 (en)
WO (1) WO2003000718A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100572391C (en) * 2006-08-30 2009-12-23 中国科学院广州生物医药与健康研究院 Beta-fodrin antigen epitope polypeptide and screening method thereof and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2188816C (en) * 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein
JPH10251157A (en) * 1996-04-23 1998-09-22 Yoshio Hayashi Medicine containing alpha-fodrin or alpha-fodrin fragment protein

Also Published As

Publication number Publication date
WO2003000718A3 (en) 2003-08-21
AU2001288087A1 (en) 2003-01-08
WO2003000718A2 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
EP1414848A4 (en) Replikin peptides and uses thereof
EP1462455A4 (en) Novel peptides and medicinal uses thereof
EP1419175A4 (en) Replikin peptides and uses thereof
AU2002307031A1 (en) Thrombospondin-2 and uses thereof
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
EP1408985A4 (en) Novel pyridopyrimidones and uses thereof
AU2002230129A1 (en) Novel physiologically active peptide and use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2002251543A1 (en) Novel atisane compound and use thereof
AUPR589701A0 (en) Novel peptide and use thereof
AU2003292774A1 (en) Novel proteins and use thereof
AU2002320621A1 (en) Structural and cytoskeleton-associated proteins
AU2002357609A1 (en) Novel proteins and dnas thereof
AU2002343516A1 (en) Structural and cytoskeleton-associated proteins
AU2002311203A1 (en) Novel polypeptide and use thereof
SG10201403662QA (en) Replikin peptides and uses thereof
AU2002230137A1 (en) Novel protein and use thereof
AU2003238562A1 (en) Novel peptide and use thereof
AU2002354188B2 (en) Novel peptides and medicinal uses thereof
AU2002341133A1 (en) Modified peptides and their uses
WO2002061044A9 (en) Synthetic peptide and uses for same
AU2002228426A1 (en) Neurotonin and use thereof